Global Structural Heart Imaging Market - 2022-2029

Global Structural Heart Imaging Market - 2022-2029

Market Overview

The global structural heart imaging market size was valued US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).

Structural heart imaging (SHI) is a cardiology field that deals with valvular and non-valvular heart disease. SHI is a molecular imaging technology that is used to screen the heart. This method entails using high-resolution cameras to create different images of the heart's inner components, which aid in the proper diagnosis of the patient's condition. The two most popular imaging techniques that closely analyze the heart structure to reveal narrowing or blockage of blood arteries are echocardiograms and angiography (MRI, CT, etc.)

Market Dynamics

Significant advances in structural heart interventions are expected to drive market growth.

Structural heart disease intervention is a game-changing breakthrough that has already displaced open surgery and enabled the treatment of a larger number of patients at a reduced cost. Significant progress has been made in structural cardiac interventions over the previous decade. The advancements in interventions and imaging are inextricably linked, from transcatheter aortic and pulmonic valve replacement to left atrial appendage occlusion procedures, percutaneous mitral repair techniques, and, more recently, transcatheter mitral valve replacement and tricuspid interventions. The commercial availability of 3-dimensional (3D) echocardiography, for instance, improved the efficiency, precision, and adaptability of the edge-to-edge repair technique. The collaboration of ultrasound and device firms continues to fuel breakthroughs in imaging that can then assist drive device innovation, thanks in part to imaging groups like the American Society of Echocardiography. Because of the imaging-intensive nature of all of these procedures, imagers must be familiar with a wide range of anatomical targets, modern imaging techniques, and the execution of numerous procedural interventions. Imagers have proven crucial to the field's continuous progress due to this information foundation. Thus, the market is expected to drive in the forecast period from the above statements.

Restraint:

Strict regulatory guidelines for equipment used in structural heart imaging, a lack of awareness regarding cardiac-specific structural imaging, and higher costs are some of the factors due to which the market is expected to hamper the market growth.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. COVID-19 patients often have symptoms and signs of a respiratory tract infection, although cardiac manifestations, such as indicators of myocardial damage, are also prevalent. Myocardial injury in COVID-19 can be caused by an oxygen supply-demand imbalance resulting from hypoxia, hypoperfusion, tachycardia, microvascular and macrovascular thrombosis, or inflammation-related injury (especially in the setting of underlying structural heart disease or coronary atherosclerosis). Imaging aids in the early detection of disease in individuals with underlying cardiovascular disorders and the detection of cardiovascular consequences in people who have already been infected with SARS-CoV-2. Although symptoms of cardiac failure can be easily diagnosed using chest radiography, chest CT, and echocardiography, the best way to examine myocardial injury is with a cardiac MRI.

Moreover, the growing body of evidence indicating a high prevalence of cardiac involvement in COVID-19 patients warrants MRI in this patient population. In contrast, there is physical contact during imaging of the Covid-19 patients. Therefore, there are chances of spreading the virus, and the government has come out with guidelines during imaging(MRI, CT, and others). Additionally, the pandemic is interrupting the supply chain, and many companies will vary to other geographic regions in the future to ensure that products remain available and protect their supply chain. Thus, the COVID-19 pandemic has affected the market. However, the situation is expected to improve gradually in the forecast period.

Segment Analysis

Angiogram segment is expected to hold the largest market share in structural heart imaging market

The angiogram segment is expected to dominate in 2020. The segment's growth is benefited because demand for various imaging modalities is projected to rise as the need for diagnostic and effective imaging for detecting SHDs, particularly CHDs, grows. Moreover, Angiogram is further segmented into MRI and CT. In the anatomic and functional evaluation of cardiovascular disease, MRI is a critical diagnostic technique. 2D phase-contrast (2D-PC) MRI has been used in several procedures for blood flow quantification. Flow in four dimensions MRI is a volumetric acquisition that records the vector field of blood flow and anatomic pictures in a time-resolved manner. Compared to 2D-PC, it also makes acquisition easier and allows for a more precise and thorough hemodynamic assessment. With advancements in accelerated imaging, 4D flow MRI scanning times have been greatly reduced while image quality has been maintained, allowing this technology to move from research to everyday clinical practice. 4D flow MRI will likely become an essential component of cardiac imaging in practices dealing with congenital and acquired structural heart disease as experience grows, and 4D flow sequences and postprocessing software become more widely available.

Moreover, the use of advanced parallel imaging techniques like k-t GRAPPA has resulted in scan times that are more realistic, such as 8-12 minutes for 4D flow MRI of the aorta and 10-20 minutes for complete heart coverage. As a result, using 4D flow MRI in a clinical setting has become increasingly practicable, as seen by an increase in recent reports on the technique's utility in patient studies for measuring cardiac and vascular hemodynamics. Thus, the market is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global structural heart imaging market

In 2020, North America accounted for the highest revenue share. The increasing prevalence of Congenital heart defects, increasing demand for technologically improved technologies for the treatment of Structural Heart Disease, increased lifestyle change adoption, increased structural disease awareness, more preventative care, favorable government policies, clinical trials, and product launches by the key players in the region are some of the factors due to which the market is expected to boost in the forecast period. For instance, according to the Centers for Disease Control and Prevention, The most frequent birth defects are congenital heart defects (CHDs), and babies are born with these problems. CHDs affect nearly 1% of―or about 40,000―births per year in the United States. Some CHDs, particularly mild forms, is growing in prevalence (the number of kids born with a heart defect divided by the total number of births), while the prevalence of other types has remained consistent. A ventricular septal defect is the most frequent type of heart abnormality (VSD). About 1 in 4 babies with CHD have a critical CHD. Infants with critical CHDs generally need surgery or other procedures in their first year of life.

Moreover, NuVera Medical, Inc. announced positive results from its non-randomized, single-center First-In-Human (FIH) study in October 2020, which looked at the NuVision ICE Catheter's feasibility in visualizing anatomical structures in patients undergoing structural heart procedures such as mitral or tricuspid valve repairs or LAAC. With improved 4D ICE imaging, the business hopes to improve the efficacy of transcatheter cardiac treatments. Thus, the North American region is expected to hold the largest market share in the forecast period from the above statements.

Competitive Landscape

Major key players in the structural heart imaging market are Boston Scientific Corporation, Circle Cardiovascular Imaging Inc., Absolute Medical Services, Inc., Pie Medical Imaging B.V., Siemens Healthineers GmbH, Cardinal Health Inc., Koninklijke Philips NV, GE HealthCare, Neusoft Medical Systems and Shimadzu Corporation.

Siemens Healthineers AG:

Overview:

Siemens Healthineers AG (formerly Siemens Healthcare, Siemens Medical Solutions, Siemens Medical Systems) is the parent company for several medical technology companies. The company dates its early beginnings in 1847 to a small family business in Berlin, co-founded by Werner von Siemens. The name Siemens Medical Solutions was adopted in 2001, and the change to Siemens Healthcare was made in 2008. In May 2016, the business operations of Siemens Healthcare GmbH were rebranded by Siemens Healthineers. The company is into manufacturing products including Angiography and Interventional X-ray Systems. Computed Tomography, Radiation Oncology, Laboratory Diagnostics Molecular Diagnostics, Molecular Imaging, Magnetic Resonance Imaging Point-of-Care Diagnostics, Refurbished Systems, Services, Syngo Imaging Software, Ultrasound and X-ray Products.

Product Portfolio:

MAGNETOM Free.Max – Open Bore MRI Scanner: MAGNETOM Free. Max is the most compact whole-body MRI, and with DryCool technology, provides a virtually helium-free infrastructure. MAGNETOM Free. Max radically simplifies infrastructure requirements to break down the barriers imposed by siting constraints.

Why Purchase the Report?

Visualize the composition of the structural heart imaging market segmentation by imaging modality, procedure type, application, end user and region highlighting the key commercial assets and players.

Identify commercial opportunities in structural heart imaging market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of structural heart imaging market- level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global structural heart imaging market report would provide an access to an approx. 45+market data table, 40+figures and 200pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Market Segmentation

Global Structural Heart Imaging Market – By Imaging Modality

Echocardiogram

Angiogram

CT

MRI

Global Structural Heart Imaging Market – By Procedure Type

Transcatheter Aortic Valve Replacement (TAVR)

Surgical Aortic Valve Replacement (SAVR)

Transcatheter Mitral Valve Repair (TMVR)

Left Atrial Appendage Closure (LAAC)

Annuloplasty

Valvuloplasty

Others

Global Structural Heart Imaging Market – By Application

Diagnosis

Surgery

Global Structural Heart Imaging Market – By End user

Hospitals

Specialty Clinics

Cardiac Centers

Diagnostic Centers

Ambulatory Surgical Centers

Others

Global Structural Heart Imaging Market - By Region

North America

South America

Europe

Asia

Middle East & Africa